---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-003840"
form_type: "8-K"
ticker: null
cik: "0001852536"
company_name: "Redox International Group, Corp."
filed_at: "2024-05-28T23:59:59+00:00"
generated_at: "2026-06-01T08:18:52.557864+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Intorio Corp. reports change of control; founder sells 89% stake; new CEO appointed

## Summary
- Founder Gagi Gogolashvili sold 2,000,000 shares (89% of outstanding) to six accredited investors on May 16, 2024.
- Gogolashvili resigned as CEO, President, and director; Han-Wen Ou appointed CEO, CFO, Secretary and sole Director.
- Company address changed from Tbilisi, Georgia to 17875 Von Karman Avenue, Irvine, California 92614.
- Dr. Han-Wen Ou holds degrees in functional medicine and clinical nutrition; previously resident at Taipei Veterans General Hospital.

## SEC filing metadata
- accession: 0001683168-24-003840
- form_type: 8-K
- cik: 0001852536
- company_name: Redox International Group, Corp.
- filed_at: 2024-05-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.01, 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1852536/000168316824003840/0001683168-24-003840-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1852536/000168316824003840/intorio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-003840
- JSON: https://secwatch.observer/filing/0001683168-24-003840.json
- Plain text: https://secwatch.observer/filing/0001683168-24-003840.txt

## Key facts
- Executive change
  Han-Wen Ou was appointed as Chief Executive Officer, Chief Financial Officer, Secretary and sole Director at Redox International Group, Corp..
  - Action: appointed
  - Role: Chief Executive Officer, Chief Financial Officer, Secretary and sole Director
  source text: Dr. Han-Wen Ou was appointed as Chief Executive Officer, Chief Financial Officer, Secretary and sole Director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1852536/000168316824003840/0001683168-24-003840-index.htm
- M&A Transactions
  Redox International Group, Corp. underwent a change of control (closed 2024-05-16).
  - Action: change of control
  - Closing: 2024-05-16
  source text: Effective May 16, 2024, Gagi Gogolashvili, the previous sole officer and director and majority shareholder of Intorio, Corp. (the “Company”), entered into a stock purchase agreements for the sale of 2,000,000 shares of Common Stock of the Company, representing approximately 89% of the issued and outstanding shares of Common Stock of the Company as of such date
  evidence_url: https://www.sec.gov/Archives/edgar/data/1852536/000168316824003840/0001683168-24-003840-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.